Literature DB >> 15193557

Schistosome transcriptome analysis at the cutting edge.

Donald P McManus1, Wei Hu, Paul J Brindley, Zheng Feng, Ze-Guang Han.   

Abstract

We live in the era of post-genomics, a term that was, until recently, inappropriate when considering the blood flukes of humans because of the relative lack of knowledge of the schistosome genome. The position has, however, changed dramatically following the recent publication of two landmark papers on transcriptome analysis of Schistosoma japonicum and Schistosoma mansoni. In a quantum leap, both studies report on the identification of many novel genes and genes not previously known from schistosomes. The datasets provide new insights into the biology of the schistosomes and offer an opportunity for identification of potential antischistosome vaccine candidates and drug targets. Remarkable recent progress has also been achieved in genomic sequencing, and completed genomes for both species can be expected shortly.

Entities:  

Mesh:

Year:  2004        PMID: 15193557     DOI: 10.1016/j.pt.2004.04.011

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  4 in total

Review 1.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

2.  Expression and characterization of two tyrosinases from the trematode Schistosoma japonicum.

Authors:  Guobin Cai; Youngan Bae; Ying Zhang; Yuan He; Mingsen Jiang; Li He
Journal:  Parasitol Res       Date:  2008-10-30       Impact factor: 2.289

Review 3.  In vitro manipulation of gene expression in larval Schistosoma: a model for postgenomic approaches in Trematoda.

Authors:  Timothy P Yoshino; Nathalie Dinguirard; Marina de Moraes Mourão
Journal:  Parasitology       Date:  2009-12-07       Impact factor: 3.234

Review 4.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.